Literature DB >> 23507358

Antismoking and potential antipsychotic effects of varenicline in subjects with schizophrenia or schizoaffective disorder: a double-blind placebo and bupropion-controlled study.

S Hossein Fatemi, Mahtab K Yousefi, Rachel E Kneeland, Stephanie B Liesch, Timothy D Folsom, Paul D Thuras.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23507358     DOI： 10.1016/j.schres.2013.02.015

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  11 in total

1.  Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.

Authors:  Karolina Kozak; Tony P George
Journal:  Expert Opin Pharmacother       Date:  2020-02-03       Impact factor: 3.889

Review 2.  Nicotine receptor partial agonists for smoking cessation.

Authors:  Kate Cahill; Nicola Lindson-Hawley; Kyla H Thomas; Thomas R Fanshawe; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2016-05-09

Review 3.  Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.

Authors:  Emmert Roberts; A Eden Evins; Ann McNeill; Debbie Robson
Journal:  Addiction       Date:  2016-01-19       Impact factor: 6.526

Review 4.  Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis.

Authors:  Taro Kishi; Nakao Iwata
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-10-05       Impact factor: 5.270

Review 5.  Interventions to reduce harm from continued tobacco use.

Authors:  Nicola Lindson-Hawley; Jamie Hartmann-Boyce; Thomas R Fanshawe; Rachna Begh; Amanda Farley; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2016-10-13

6.  Smoking reduction interventions for smoking cessation.

Authors:  Nicola Lindson; Elias Klemperer; Bosun Hong; José M Ordóñez-Mena; Paul Aveyard
Journal:  Cochrane Database Syst Rev       Date:  2019-09-30

7.  Antidepressants for smoking cessation.

Authors:  Seth Howes; Jamie Hartmann-Boyce; Jonathan Livingstone-Banks; Bosun Hong; Nicola Lindson
Journal:  Cochrane Database Syst Rev       Date:  2020-04-22

Review 8.  Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis.

Authors:  Emily Peckham; Sally Brabyn; Liz Cook; Garry Tew; Simon Gilbody
Journal:  BMC Psychiatry       Date:  2017-07-14       Impact factor: 3.630

Review 9.  Review of pharmacotherapy for smoking cessation in patients with schizophrenia.

Authors:  Avery E Shawen; Shannon J Drayton
Journal:  Ment Health Clin       Date:  2018-03-26

Review 10.  Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis.

Authors:  Kyla H Thomas; Richard M Martin; Duleeka W Knipe; Julian P T Higgins; David Gunnell
Journal:  BMJ       Date:  2015-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.